Skip to main content
Clinical Trials/NCT01456884
NCT01456884
Completed
N/A

Music Therapy as a Pain Modifying Intervention in Children With Life-limiting Neurological Impairments and Metabolic Conditions

University of British Columbia1 site in 1 country13 target enrollmentJanuary 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Neurological Impairment
Sponsor
University of British Columbia
Enrollment
13
Locations
1
Primary Endpoint
Behavioural Pain Scores
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this within-subjects randomized controlled trial is to determine whether two music therapy interventions are efficacious in reducing pain symptoms, in order to improve the quality of care for children in pediatric hospice. The investigators hypothesize that both music therapy interventions, live guitar and vocal intervention and vibroacoustic intervention, will reduce behavioural pain scores and that behavioural pain scores will correlate with physiological outcome measures.

Detailed Description

Effective pain management in pediatric palliative care is a quality of life issue for patients, families and professionals. Current research supports the use of music therapy to assist with pain management in pediatric medical settings. However, little research has been done to explore the use of music therapy for reducing pain in children with life-limiting neurological impairments or metabolic conditions. As the first known project to examine the effects of music therapy on pain symptoms with children who have life-limiting neurological impairments or metabolic disorders, this study will expand the evidence-base for practice with this population. It is imperative that an evidence base for music therapy in this area be established, so that the most effective interventions can be provided to these vulnerable children.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
August 2014
Last Updated
8 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Liisa Holsti

Principle Investigator

University of British Columbia

Eligibility Criteria

Inclusion Criteria

  • Children, ages 1-19, who have been diagnosed with life-limiting neurological impairments and metabolic conditions
  • Cognitive functioning level of one year or less will be enrolled in the study
  • Receiving respite or symptom management care at the time of admission to the Canuck Place Children's Hospice
  • Guardians must be able to provide written consent in English; interpreters will be available if a guardian needs clarification on specific points.

Exclusion Criteria

  • Children who are actively dying (i.e. admitted for end-of-life care or determined by physicians to require immediate end-of-life care)
  • Any history of adverse responses to live or recorded music or to vibroacoustic stimulation
  • Severe to profound hearing impairment will be excluded.

Outcomes

Primary Outcomes

Behavioural Pain Scores

Time Frame: Participants will be observed for a total of 3 hours during one hospice admission, an expected average of one week

Non-communicating children's pain checklist scores.

Secondary Outcomes

  • Physiological measures(Participants will be observed for a total of 3 hours during one hospice admission, an expected average of one week)

Study Sites (1)

Loading locations...

Similar Trials